BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17105243)

  • 1. Synthesis of fluorescent analogs of alpha-conotoxin MII.
    Vishwanath VA; McIntosh JM
    Bioconjug Chem; 2006; 17(6):1612-7. PubMed ID: 17105243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
    McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
    Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
    Ning H; Huang B; Tae HS; Liu Z; Yu S; Li L; Zhang L; Adams DJ; Guo C; Dai Q
    J Neurochem; 2021 Oct; 159(1):90-100. PubMed ID: 34008858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
    van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
    Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
    Luo S; Zhangsun D; Schroeder CI; Zhu X; Hu Y; Wu Y; Weltzin MM; Eberhard S; Kaas Q; Craik DJ; McIntosh JM; Whiteaker P
    FASEB J; 2014 Apr; 28(4):1842-53. PubMed ID: 24398291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of disulfide connectivity on structure and bioactivity of α-conotoxin TxIA.
    Wu Y; Wu X; Yu J; Zhu X; Zhangsun D; Luo S
    Molecules; 2014 Jan; 19(1):966-79. PubMed ID: 24434670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
    Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
    Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors.
    Inserra MC; Kompella SN; Vetter I; Brust A; Daly NL; Cuny H; Craik DJ; Alewood PF; Adams DJ; Lewis RJ
    Biochem Pharmacol; 2013 Sep; 86(6):791-9. PubMed ID: 23924607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor.
    Luo S; Akondi KB; Zhangsun D; Wu Y; Zhu X; Hu Y; Christensen S; Dowell C; Daly NL; Craik DJ; Wang CI; Lewis RJ; Alewood PF; Michael McIntosh J
    J Biol Chem; 2010 Apr; 285(16):12355-66. PubMed ID: 20145249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent α-Conotoxin [Q1G, ΔR14]LvIB Identifies the Distribution of
    Shan H; Wang N; Gao X; Wang Z; Yu J; Zhangsun D; Zhu X; Luo S
    Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786593
    [No Abstract]   [Full Text] [Related]  

  • 12. Venomic study on cone snails (Conus spp.) from South Africa.
    Kauferstein S; Porth C; Kendel Y; Wunder C; Nicke A; Kordis D; Favreau P; Koua D; Stöcklin R; Mebs D
    Toxicon; 2011 Jan; 57(1):28-34. PubMed ID: 20933537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
    Blanchfield JT; Dutton JL; Hogg RC; Gallagher OP; Craik DJ; Jones A; Adams DJ; Lewis RJ; Alewood PF; Toth I
    J Med Chem; 2003 Mar; 46(7):1266-72. PubMed ID: 12646037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.
    Wu Y; Zhangsun D; Zhu X; Kaas Q; Zhangsun M; Harvey PJ; Craik DJ; McIntosh JM; Luo S
    J Med Chem; 2017 Jul; 60(13):5826-5833. PubMed ID: 28603989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an α 4/7-Conotoxin LvIF from
    Guo M; Yu J; Zhu X; Zhangsun D; Luo S
    Mar Drugs; 2021 Jul; 19(7):. PubMed ID: 34356823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
    Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
    J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices.
    Kaiser SA; Soliakov L; Harvey SC; Luetje CW; Wonnacott S
    J Neurochem; 1998 Mar; 70(3):1069-76. PubMed ID: 9489727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alexa Fluor 546-ArIB[V11L;V16A] is a potent ligand for selectively labeling alpha 7 nicotinic acetylcholine receptors.
    Hone AJ; Whiteaker P; Mohn JL; Jacob MH; McIntosh JM
    J Neurochem; 2010 Aug; 114(4):994-1006. PubMed ID: 20492354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short framework-III (mini-M-2) conotoxin from the venom of a vermivorous species, Conus archon, inhibits human neuronal nicotinic acetylcholine receptors.
    Hernández-Sámano AC; Falcón A; Zamudio F; Michel-Morfín JE; Landa-Jaime V; López-Vera E; Jeziorski MC; Aguilar MB
    Peptides; 2022 Jul; 153():170785. PubMed ID: 35307452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of potency on alpha-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors.
    Everhart D; Cartier GE; Malhotra A; Gomes AV; McIntosh JM; Luetje CW
    Biochemistry; 2004 Mar; 43(10):2732-7. PubMed ID: 15005608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.